ÂÜÀòÂÒÂ×

Andrew Aymeloglu is an experienced individual who has held various engineering and advisory roles in companies such as Hexagon Bio, Alcor Life Extension Foundation, Qualia Labs, Inc., Blend, Anduin Transactions, and Palantir Technologies. Andrew is also a board member at Alcor Life Extension Foundation and has a background in math and computer science from Stanford University. Andrew has been involved in mining genomes for drugs and has experience as a director of engineering and software engineer. At Stanford University, Andrew served as a section leader, TA, and lecturer for CS106 courses.